May 1 - 5, 2017
Meet Genedata experts at PEGS Boston Protein Engineering Summit in Boston, MA.
Don't miss the opportunity to see how Genedata solutions efficiently support the whole biopharmaceutical R&D workflow, including screening and protein engineering, expression and purification, characterization and analysis of protein therapeutics, cell line design and development, bioprocess optimization, and quality control of biologicals.
To get more information about Genedata solutions, please contact email@example.com.
Design and Evaluation of Next-Generation Biologics for Cancer Immunotherapy
Maria Wendt, PhD, Head of Science, Genedata
Bispecific Antibodies for Cancer Immunotherapy Session
Thursday, May 4 | 15:20 - 15:50
Bi- and multi-specific antibodies, Ab-cytokine fusion proteins, non-Ig scaffolds, chimeric antigen receptors (CARs), engineered TCRs and TCR-based bispecific constructs can provide significant advantages for use in cancer immunotherapy. However, as highly engineered molecules they pose new design, engineering, cloning, expression, purification, and analytics challenges. Genedata Biologics enables the automated design, screening, production, and testing of large panels of these candidate therapeutic molecules and includes built-in tools for developability and manufacturability assessments.